Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
about
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
@en
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis
@nl
type
label
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
@en
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis
@nl
prefLabel
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
@en
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis
@nl
P767
P1476
Norwegian Study of Oral Cladri ...... ticenter Non-inferiority Study
@en
P17
P1813
NOR-MS
@en
P3098
NCT04121403
P4844
P580
2019-10-01T00:00:00Z
P582
2023-07-01T00:00:00Z